Literature DB >> 10722634

Localization of Haemophilus ducreyi at the pustular stage of disease in the human model of infection.

M E Bauer1, S M Spinola.   

Abstract

To localize Haemophilus ducreyi in vivo, human subjects were experimentally infected with H. ducreyi until they developed a painful pustule or for 14 days. Lesions were biopsied, and biopsy samples were fixed in 4% paraformaldehyde, and cryosectioned. Sections were stained with polyclonal anti-H. ducreyi antiserum or H. ducreyi-specific monoclonal antibodies (MAbs) and fluorescently tagged secondary antibodies and examined by confocal microscopy. We identified H. ducreyi in 16 of 18 pustules but did not detect bacteria in the one papule examined. H. ducreyi was observed as individual cells and in clumps or chains. Staining with MAbs 2D8, 5C9, 3B9, 2C7, and 9D12 demonstrated that H. ducreyi expresses the major pilus subunit, FtpA, the 28-kDa outer membrane protein Hlp, the 18-kDa outer membrane protein PAL, and the major outer membrane protein (MOMP) or OmpA2 in vivo. By dual staining with polyclonal anti-H. ducreyi antiserum and MAbs that recognize human skin components, we observed bacteria within the neutrophilic infiltrates of all positively staining pustules and in the dermis of 10 of 16 pustules. We were unable to detect bacteria associated with keratinocytes in the samples examined. The data suggest that H. ducreyi is found primarily in association with neutrophils and in the dermis at the pustular stage of disease in the human model of infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10722634      PMCID: PMC97418          DOI: 10.1128/IAI.68.4.2309-2314.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  32 in total

1.  A pilus-deficient mutant of Haemophilus ducreyi is virulent in the human model of experimental infection.

Authors:  J A Al-Tawfiq; M E Bauer; K R Fortney; B P Katz; A F Hood; M Ketterer; M A Apicella; S M Spinola
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

2.  The major outer membrane protein of Haemophilus ducreyi consists of two OmpA homologs.

Authors:  J Klesney-Tait; T J Hiltke; I Maciver; S M Spinola; J D Radolf; E J Hansen
Journal:  J Bacteriol       Date:  1997-03       Impact factor: 3.490

3.  Gross and microscopic features in chancroid: a study in 200 new culture-proven cases in San Salvador.

Authors:  C Ortíz-Zepeda; E Hernández-Pérez; R Marroquín-Burgos
Journal:  Sex Transm Dis       Date:  1994 Mar-Apr       Impact factor: 2.830

4.  Effect of normal and immune sera on Haemophilus ducreyi 35000HP and its isogenic MOMP and LOS mutants.

Authors:  T J Hiltke; M E Bauer; J Klesney-Tait; E J Hansen; R S Munson; S M Spinola
Journal:  Microb Pathog       Date:  1999-02       Impact factor: 3.738

5.  A morphological study of penile chancroid lesions in human immunodeficiency virus (HIV)-positive and -negative African men with a hypothesis concerning the role of chancroid in HIV transmission.

Authors:  C M Magro; A N Crowson; M Alfa; A Nath; A Ronald; J O Ndinya-Achola; J Nasio
Journal:  Hum Pathol       Date:  1996-10       Impact factor: 3.466

6.  Experimental human infection with Haemophilus ducreyi.

Authors:  S M Spinola; L M Wild; M A Apicella; A A Gaspari; A A Campagnari
Journal:  J Infect Dis       Date:  1994-05       Impact factor: 5.226

7.  An isogenic hemoglobin receptor-deficient mutant of Haemophilus ducreyi is attenuated in the human model of experimental infection.

Authors:  J A Al-Tawfiq; K R Fortney; B P Katz; A F Hood; C Elkins; S M Spinola
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

8.  Evaluation of an isogenic major outer membrane protein-deficient mutant in the human model of Haemophilus ducreyi infection.

Authors:  R E Throm; J A Al-Tawfiq; K R Fortney; B P Katz; A F Hood; C A Slaughter; E J Hansen; S M Spinola
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

9.  Haemophilus ducreyi attaches to and invades human epithelial cells in vitro.

Authors:  P A Totten; J C Lara; D V Norn; W E Stamm
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

10.  Characterization of an 18,000-molecular-weight outer membrane protein of Haemophilus ducreyi that contains a conserved surface-exposed epitope.

Authors:  S M Spinola; G E Griffiths; J Bogdan; M A Menegus
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

View more
  38 in total

1.  Haemophilus ducreyi associates with phagocytes, collagen, and fibrin and remains extracellular throughout infection of human volunteers.

Authors:  M E Bauer; M P Goheen; C A Townsend; S M Spinola
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

2.  Transcription of candidate virulence genes of Haemophilus ducreyi during infection of human volunteers.

Authors:  R E Throm; S M Spinola
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

Review 3.  Immunopathogenesis of Haemophilus ducreyi infection (chancroid).

Authors:  Stanley M Spinola; Margaret E Bauer; Robert S Munson
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

4.  Differences in host susceptibility to disease progression in the human challenge model of Haemophilus ducreyi infection.

Authors:  Stanley M Spinola; Cliffton T H Bong; Andrew L Faber; Kate R Fortney; Stacy L Bennett; Carisa A Townsend; Beth E Zwickl; Steven D Billings; Tricia L Humphreys; Margaret E Bauer; Barry P Katz
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

5.  Experimental infection with Haemophilus ducreyi in persons who are infected with HIV does not cause local or augment systemic viral replication.

Authors:  Diane M Janowicz; Klara Tenner-Racz; Paul Racz; Tricia L Humphreys; Carol Schnizlein-Bick; Kate R Fortney; Beth Zwickl; Barry P Katz; James J Campbell; David D Ho; Stanley M Spinola
Journal:  J Infect Dis       Date:  2007-04-05       Impact factor: 5.226

6.  Outer membrane protein DsrA is the major fibronectin-binding determinant of Haemophilus ducreyi.

Authors:  Isabelle Leduc; C Dinitra White; Igor Nepluev; Robert E Throm; Stanley M Spinola; Christopher Elkins
Journal:  Infect Immun       Date:  2008-01-22       Impact factor: 3.441

7.  Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling.

Authors:  Jason R Mock; Merja Vakevainen; Kaiping Deng; Jo L Latimer; Jennifer A Young; Nicolai S C van Oers; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

8.  The Haemophilus ducreyi trimeric autotransporter adhesin DsrA protects against an experimental infection in the swine model of chancroid.

Authors:  William G Fusco; Neelima R Choudhary; Patty A Routh; Melissa S Ventevogel; Valerie A Smith; Gary G Koch; Glen W Almond; Paul E Orndorff; Gregory D Sempowski; Isabelle Leduc
Journal:  Vaccine       Date:  2014-05-18       Impact factor: 3.641

9.  Expression of the LspA1 and LspA2 proteins by Haemophilus ducreyi is required for virulence in human volunteers.

Authors:  Diane M Janowicz; Kate R Fortney; Barry P Katz; Jo L Latimer; Kaiping Deng; Eric J Hansen; Stanley M Spinola
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

10.  Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.

Authors:  Merja Vakevainen; Steven Greenberg; Eric J Hansen
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.